Report - b Enhances the In Vivo Antitumor Ef Targeted Therapy · genesis (6, 7). Strategies to target EGFR have focused on either EGFR tyrosine kinase inhibitors (TKI) or monoclo-nal antibodies

Please pass captcha verification before submit form